Improving diabetes technology use in youth with Type 1 Diabetes
Improving Outcomes in Pediatric Diabetes: Building the Evidence Base to Inform Effective Diabetes Technology Interventions
NA · Stanford University · NCT05488119
This study is trying to find out how to help young people with Type 1 Diabetes, ages 12-21, use diabetes technology better by understanding their challenges and experiences with their families.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | Stanford University (other) |
| Locations | 1 site (Stanford, California) |
| Trial ID | NCT05488119 on ClinicalTrials.gov |
What this trial studies
This research aims to understand and enhance the utilization of diabetes technology among youth aged 12-21 with Type 1 Diabetes who have public insurance. The study will identify barriers and promoters affecting the uptake of diabetes technology and develop targeted interventions to increase its use. By focusing on the family dynamics and the experiences of both youth and their guardians, the research seeks to build a comprehensive evidence base that can inform future strategies for improving diabetes management in this population.
Who should consider this trial
Good fit: Ideal candidates for this study are youth aged 12-21 with a diagnosis of Type 1 Diabetes who are covered by public insurance and live with a parent or guardian.
Not a fit: Patients who do not have Type 1 Diabetes or are outside the age range of 12-21 will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to increased use of diabetes technology, resulting in better health outcomes for youth with Type 1 Diabetes.
How similar studies have performed: Other studies have shown success in increasing diabetes technology utilization among youth, but this specific approach focusing on public insurance and family dynamics is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The investigators will include youth aged 12-21 years in this study. The lower limit of 12 years was selected as this is the age when youth are able to understand and reflect on the topics discussed in the survey measures and focus groups. The upper limit of 21 years was selected as this is the upper limit of public payer coverage (for example, California Children's Services). This aim focuses specifically on the family (youth and parent/guardian) factors that determine diabetes technology use and thus requires that youth are living with their parent/guardian in order to be included in this study. For youth under 18, the investigators will obtain both parental permission and youth assent to participate in the study. For those older than 18, the investigators will obtain consent from the youth alone. Exclusion Criteria: * Diabetes diagnosis in youth other than type 1 * T1D youth less than the age of 12 or older than 21 * non-public payer insurance * caregivers not living with the youth with type 1 diabetes
Where this trial is running
Stanford, California
- Stanford University — Stanford, California, United States (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Type 1 Diabetes, Diabetes Technology, Pediatric Type 1 Diabetes